9-98056809-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_018946.4(NANS):āc.1A>Gā(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0000144 in 1,592,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 34)
Exomes š: 0.000015 ( 0 hom. )
Consequence
NANS
NM_018946.4 start_lost
NM_018946.4 start_lost
Scores
2
10
4
Clinical Significance
Conservation
PhyloP100: 6.70
Genes affected
NANS (HGNC:19237): (N-acetylneuraminate synthase) This gene encodes an enzyme that functions in the biosynthetic pathways of sialic acids. In vitro, the encoded protein uses N-acetylmannosamine 6-phosphate and mannose 6-phosphate as substrates to generate phosphorylated forms of N-acetylneuraminic acid (Neu5Ac) and 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN), respectively; however, it exhibits much higher activity toward the Neu5Ac phosphate product. In insect cells, expression of this gene results in Neu5Ac and KDN production. This gene is related to the E. coli sialic acid synthase gene neuB, and it can partially restore sialic acid synthase activity in an E. coli neuB-negative mutant. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-98056809-A-G is Pathogenic according to our data. Variant chr9-98056809-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 810396.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NANS | NM_018946.4 | c.1A>G | p.Met1? | start_lost | 1/6 | ENST00000210444.6 | NP_061819.2 | |
TRIM14 | XM_047424162.1 | c.*29-20996T>C | intron_variant | XP_047280118.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NANS | ENST00000210444.6 | c.1A>G | p.Met1? | start_lost | 1/6 | 1 | NM_018946.4 | ENSP00000210444 | P1 | |
NANS | ENST00000480925.1 | n.40A>G | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
NANS | ENST00000495319.1 | n.42A>G | non_coding_transcript_exon_variant | 1/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151634Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
1
AN:
151634
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000164 AC: 4AN: 243952Hom.: 0 AF XY: 0.0000300 AC XY: 4AN XY: 133258
GnomAD3 exomes
AF:
AC:
4
AN:
243952
Hom.:
AF XY:
AC XY:
4
AN XY:
133258
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000153 AC: 22AN: 1440680Hom.: 0 Cov.: 41 AF XY: 0.0000167 AC XY: 12AN XY: 717044
GnomAD4 exome
AF:
AC:
22
AN:
1440680
Hom.:
Cov.:
41
AF XY:
AC XY:
12
AN XY:
717044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151634Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74070
GnomAD4 genome
AF:
AC:
1
AN:
151634
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
74070
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
Asia WGS
AF:
AC:
1
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2019 | - - |
Spondyloepimetaphyseal dysplasia, Genevieve type Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital | Apr 25, 2022 | The homozygous start-loss variant c.1A>G (p.1M?) has an allele frequency-0.0018% in gnomAD (aggregated) database and 0.0033% in 1000g databases. In-silico bioinformatic software predicts this variant by mutation taster as Disease causing. Phenotype observed were micromelia, bilateral hydrocephalus, cerebellar hypoplasia, hypoplastic nasal bone and hydrops. Spondyloepimetaphyseal dysplasia, Camera-Genevieve type is an autosomal recessive disorder. This is also known as NANS-CDG as sialic acid plays a vital role in multiple cellular functions. We classify this variant as likely pathogenic based on the phenotypes. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Benign
T
MutationTaster
Benign
D
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MutPred
Loss of loop (P = 0.0804);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at